One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Translating Results from VARSITY to Real World: Adalimumab vs Vedolizumab as First-line Biological in Moderate to Severe IBD
Annick Moens, PhD, Bram Verstockt, PhD, Dahham Alsoud, PhD, João Sabino, PhD, Marc Ferrante, PhD, Séverine Vermeire, PhD
doi : 10.1093/ibd/izab257
Inflammatory Bowel Diseases, Volume 28, Issue 8, August 2022, Pages 1135–1142
Mechanoscopy: A Novel Device and Procedure for in vivo Detection of Chronic Colitis in Mice
Shijie He, PhD, Dara A Azar, PhD, Farid Nasr Esfahani, MD, Golara A Azar, BS, Tarek Shazly, PhD, Nima Saeidi, PhD
doi : 10.1093/ibd/izac046
Alcohol Consumption is Associated With An Increased Risk of Microscopic Colitis: Results From 2 Prospective US Cohort Studies
Blake Niccum, MD, Kevin Casey, MPH, Kristin Burke, MD, Emily W Lopes, MD, Paul Lochhead, MBChB, PhD, Ashwin Ananthakrishnan, MBBS, MPH, James M Richter, MD, Jonas F Ludvigsson, MD, PhD, Andrew T Chan, MD, MPH, Hamed Khalili, MD, MPH
doi : 10.1093/ibd/izab220
Probability of Stoma in Incident Patients With Crohn’s Disease in Sweden 2003-2019: A Population-based Study
Åsa H Everhov, MD, PhD, Thordis Disa Kalman, MD, PhD, Jonas Söderling, PhD, Caroline Nordenvall, MD, PhD, Jonas Halfvarson, MD, PhD, Anders Ekbom, MD, PhD, Jonas F Ludvigsson, MD, PhD, Ola Olén, MD, PhD, Pär Myrelid, MD, PhD
doi : 10.1093/ibd/izab245
Cost-effectiveness of Venous Thromboembolism Prophylaxis After Hospitalization in Patients With Inflammatory Bowel Disease
Kate E Lee, BA, Francesca Lim, MS, Jean-Frederic Colombel, MD, Chin Hur, MD, MPH, Adam S Faye, MD, MS
doi : 10.1093/ibd/izab246
Interventions to Improve Adherence to Preventive Care in Inflammatory Bowel Disease: A Systematic Review
Natalie Yu, BBiomed, Chamara Basnayake, MBBS, PhD, William Connell, MBBS, MD, Nik Sheng Ding, MBBS, PhD, Emily Wright, MBBS, PhD, Annalise Stanley, BS (Hons), RN, Stephanie Fry, BN, RN, Amy Wilson-O’Brien, BS (Hons), PhD, Ola Niewiadomski, MBBS, PhD, Mark Lust, MBBS, PhD, Julien Schulberg, MBBS, BMedSci, Michael A Kamm, MBBS, MD
doi : 10.1093/ibd/izab247
IBD Disability Index Is Associated With Both Direct and Indirect Costs of Inflammatory Bowel Disease
Leigh Anne Shafer, PhD, Seth Shaffer, MD, MPH, Julia Witt, PhD, Zoann Nugent, PhD, Charles N Bernstein, MD
doi : 10.1093/ibd/izab248
Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAID
Catherine Reenaers, MD, PhD, Arnaud de Roover, MD, PhD, Laurent Kohnen, MD, Maria Nachury, MD, Marion Simon, MD, Guillaume Pourcher, MD, Caroline Trang-Poisson, MD, Sylvie Rajca, MD, Simon Msika, MD, PhD, Stéphanie Viennot, MD, Romain Alttwegg, MD, Mélanie Serrero, MD, Philippe Seksik, MD, PhD, Laurent Peyrin-Biroulet, MD, PhD, Laurence Picon, MD, Céline Bourbao Tournois, MD, Renaud Gontier, MD, Cyrielle Gilletta, MD, Carmen Stefanescu, MD, David Laharie, MD, PhD, Xavier Roblin, MD, PhD, Stéphane Nahon, MD, PhD, Guillaume Bouguen, MD, PhD, Franck Carbonnel, MD, PhD, Alain Attar, MD, Edouard Louis, MD, PhD, Benoît Coffin, MD, PhD
doi : 10.1093/ibd/izab249
Effects of JAK1-Preferential Inhibitor Filgotinib on Circulating Biomarkers and Whole Blood Genes/Pathways of Patients With Moderately to Severely Active Crohn’s Disease
Xavier Roblin, MD, PhD, Adrian Serone, PhD, Oh Kyu Yoon, PhD, Luting Zhuo,, MS, Ethan Grant, PhD, Jacky Woo, PhD, MBA, Jinfeng Liu, PhD, René Galien, PhD, Geert D’Haens, MD, PhD
doi : 10.1093/ibd/izab253
Vedolizumab Antagonizes MAdCAM-1-Dependent Human Placental Cytotrophoblast Adhesion and Invasion In Vitro
Adam Blaisdell, MD, PhD, Yan Zhou, MD, MS, Michael G Kattah, MD, PhD, Susan J Fisher, PhD, Uma Mahadevan, MD
doi : 10.1093/ibd/izac056
Divergent Adaptations in Autonomic Nerve Activity and Neuroimmune Signaling Associated With the Severity of Inflammation in Chronic Colitis
Rhian Stavely, PhD, Ahmed A Rahman, PhD, Lauren Sahakian, BSc, Monica D Prakash, PhD, Ainsley M Robinson, PhD, Majid Hassanzadeganroudsari, MSc, Rhiannon T Filippone, BSc, Sarah Fraser, PhD, Rajaraman Eri, PhD, Joel C Bornstein, PhD, Vasso Apostolopoulos, PhD, Kulmira Nurgali, PhD
doi : 10.1093/ibd/izac060
Effects of CB2 and TRPV1 Stimulation on Osteoclast Overactivity Induced by Iron in Pediatric Inflammatory Bowel Disease
Chiara Tortora, PhD, Alessandra Di Paola, PhD, Mara Creoli,, Maura Argenziano, PhD, Massimo Martinelli, MD, Erasmo Miele, MD, Francesca Rossi, MD, Caterina Strisciuglio, MD
doi : 10.1093/ibd/izac073
Early Diagnosis, Early Stratification, and Early Intervention to Deliver Precision Medicine in IBD
Nurulamin M Noor, MRCP, Paula Sousa, MD, Stéphane Paul, MD, Xavier Roblin, MD
doi : 10.1093/ibd/izab228
COVID-19 and Outcomes in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
Kartikeya Tripathi, MD, Gala Godoy Brewer, MD, Minh Thu Nguyen, Yuvaraj Singh, MD, Mohamed Saleh Ismail, MD, Jenny S Sauk, MD, Alyssa M Parian, MD, Berkeley N Limketkai, MD, PhD
doi : 10.1093/ibd/izab236
Influence and Implications of the Molecular Paradigm of Nitric Oxide Underlying Inflammatory Reactions of the Gastrointestinal Tract of Dog: A Major Hallmark of Inflammatory Bowel Disease
Tanmoy Rana, PhD
doi : 10.1093/ibd/izac017
High Degree of Practice Variability in Colonic Dysplasia Surveillance for Patients With Inflammatory Bowel Disease
James D Lewis, MD, MSCE, Raymond K Cross, MD, MS, Millie Long, MD, MPH, Siddharth Singh, MD, MS, Hans Herfarth, MD, PhD, Alexandra Weiss, MD, Anna Buchner, MD
doi : 10.1093/ibd/izab347
Underrepresentation of Minorities and Lack of Race Reporting in Ulcerative Colitis Drug Development Clinical Trials
Rocio Sedano, MD, Malcolm Hogan, Cassandra McDonald, Tina Aswani-Omprakash, Christopher Ma, MD, Vipul Jairath, MD, PhD
doi : 10.1093/ibd/izab362
Current Venous Thromboembolism Chemoprophylaxis Practices After Surgery for Inflammatory Bowel Diseases
Stephen J Bickston, MD, Michael V Patrone, MD
doi : 10.1093/ibd/izac086
Serum Levels of Infliximab Biosimilar in a Child Delivered From a Mother Treated for Ulcerative Colitis
Ami Kawamoto, MBBS, PhD, Toshimitsu Fujii, MD, PhD, Ryuji Mitani, MD, PhD, Yasuhiro Suzuki, MD, Tsunehito Yauchi, MD, PhD, Ryuichi Okamoto, MD, PhD
doi : 10.1093/ibd/izac111
A Case of Ulcerative Colitis Relapse Characterized by Systemic Type I Interferon Responses after COVID-19 Vaccination
Yasuhiro Masuta, MD, Tomohiro Watanabe, MD, PhD, Kosuke Minaga, MD, PhD, Masatoshi Kudo, MD, PhD
doi : 10.1093/ibd/izac031
Ulcerative Colitis Relapse After COVID-19 Vaccination: Correspondence
Rujittika Mungmunpuntipantip, PhD, Viroj Wiwanitkit, MD
doi : 10.1093/ibd/izac080
Reply to Response to “‘A Case of Ulcerative Colitis Relapse Characterized by Systemic Type I Interferon Responses After COVID-19 Vaccination’� by Mungmunpuntipantip and Wiwanitkiton
Yasuhiro Masuta, MD, Tomohiro Watanabe, MD, PhD, Kosuke Minaga, MD, PhD, Masatoshi Kudo, MD, PhD
doi : 10.1093/ibd/izac081
Hypertensive Emergency After Initiating Ozanimod: A Case Report
David K Choi, PharmD, David T Rubin, MD, Archariya Puangampai, PharmD, Noa Cleveland, MD
doi : 10.1093/ibd/izac032
Colon Cancer in Ulcerative Colitis: A Mimicker of a Flare of Disease
Amit Yadav, MD, Anuraag Jena, MD, DM, Kollabathula Arpitha, MD, Jimil Shah, MD, DM, Kim Vaiphei, MD, Usha Dutta, MD, DM, Anupam Kumar Singh, MD, DM
doi : 10.1093/ibd/izac033
Synchronous Multifocal Adenomatous Dysplasia and Post-transplant Lymphoproliferative Disorder Confined to the Colon in a Patient with Ulcerative Colitis After Liver Transplant
Adam R Peterson, MBBS, Ashish Srinivasan, MBBS, David Proud, MBBS, Louise Jackett, MBBS, Paul Gow, MD, Peter De Cruz, PhD, Matthew C Choy, PhD
doi : 10.1093/ibd/izac034
Letter to the Editor: Too Soon to Dismiss Inflammation-Related Differences in the Mucosa-Associated Microbiota in Crohn’s Disease Patients
Josie Libertucci, PhD, Usha Dutta, MD, David Armstrong, MA, MB, BChir
doi : 10.1093/ibd/izac041
Reply to “Too Soon to Dismiss Inflammation-Related Differences in the Mucosa-Associated Microbiota in Crohn’s Disease Patients�
Maya Olaisen, MD, PhD, Reidar Fossmark, MD, PhD
doi : 10.1093/ibd/izac047
Positive Gluten Sensitivity Serologies and the Impact of Gluten-free Diet in Patients With IBD
Maria M Dahar, MD, Claudia Ramos Rivers, MD, Maaz Ahsan, MD, Elyse Johnston, MD, Jeffrey M Dueker, MD, MPH, Marc Schwartz, MD, Therezia Alchoufete, MS, RDN, LDN, David G Binion, MD
doi : 10.1093/ibd/izac045
Are Ulcerative Colitis and Diverticulitis Connected by the Same Hub?
Fernando Tavarela Veloso
doi : 10.1093/ibd/izac042
Ulcerative Colitis and Diverticulitis Are Possibly Connected to the Same Hub
Badar Hasan, MD, Asad Ur Rahman, MD
doi : 10.1093/ibd/izac057
